Literature DB >> 16522257

Studies of HIV-associated immune responses in lymphoid compartments.

Susanna Grundström1, Jan Andersson.   

Abstract

Acute HIV-1 infection results in profound depletion of CD4+ memory T cells in lymphoid tissue (LT) and subsequent persistent replication in activated CD4+ T cells despite induction of an HIV-specific cell-mediated immune response. Interferon-alpha, proinflammatory cytokines, and beta-chemokine production is present in LT. However, impaired expression of co-stimulatory molecules including CD80, CD86, and CD40L may contribute to low polyfunctional CD4+ T cell as well CD8+ T-cell activity. Accumulation of regulatory CD4+ T cells in LT may add to the lack of HIV-specific CD4+ T-cell proliferation and dysfunctional cytotoxic CD8+ T-cell response in LT.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522257     DOI: 10.1007/s11904-006-0006-1

Source DB:  PubMed          Journal:  Curr HIV/AIDS Rep        ISSN: 1548-3568            Impact factor:   5.071


  50 in total

1.  Viral load and immunophenotype of cells obtained from lymph nodes by fine needle aspiration as compared with peripheral blood cells in HIV-infected patients.

Authors:  P R Meylan; P Bürgisser; C Weyrich-Suter; F Spertini
Journal:  J Acquir Immune Defic Syndr Hum Retrovirol       Date:  1996-09

2.  CD4+ T-cell death induced by infectious and noninfectious HIV-1: role of type 1 interferon-dependent, TRAIL/DR5-mediated apoptosis.

Authors:  Jean-Philippe Herbeuval; Jean-Charles Grivel; Adriano Boasso; Andrew W Hardy; Claire Chougnet; Matthew J Dolan; Hideo Yagita; Jeffrey D Lifson; Gene M Shearer
Journal:  Blood       Date:  2005-07-26       Impact factor: 22.113

3.  The Fas/FasL system and T cell apoptosis in HIV-1-infected lymphoid tissue during highly active antiretroviral therapy.

Authors:  A M Dyrhol-Riise; G Stent; B I Røsok; P Voltersvik; J Olofsson; B Asjö
Journal:  Clin Immunol       Date:  2001-11       Impact factor: 3.969

4.  Decreased CD40 ligand induction in CD4 T cells and dysregulated IL-12 production during HIV infection.

Authors:  G Vanham; L Penne; J Devalck; L Kestens; R Colebunders; E Bosmans; K Thielemans; J L Ceuppens
Journal:  Clin Exp Immunol       Date:  1999-08       Impact factor: 4.330

5.  Early reduction of immune activation in lymphoid tissue following highly active HIV therapy.

Authors:  J Andersson; T E Fehniger; B K Patterson; J Pottage; M Agnoli; P Jones; H Behbahani; A Landay
Journal:  AIDS       Date:  1998-07-30       Impact factor: 4.177

6.  Levels of interleukin-15 in plasma may predict a favorable outcome of structured treatment interruption in patients with chronic human immunodeficiency virus infection.

Authors:  Massimo Amicosante; Fabrizio Poccia; Cristiana Gioia; Carla Montesano; Simone Topino; Federico Martini; Pasquale Narciso; Leopoldo P Pucillo; Gianpiero D'Offizi
Journal:  J Infect Dis       Date:  2003-08-18       Impact factor: 5.226

7.  Modulation of tryptophan catabolism by regulatory T cells.

Authors:  Francesca Fallarino; Ursula Grohmann; Kwang Woo Hwang; Ciriana Orabona; Carmine Vacca; Roberta Bianchi; Maria Laura Belladonna; Maria Cristina Fioretti; Maria-Luisa Alegre; Paolo Puccetti
Journal:  Nat Immunol       Date:  2003-10-26       Impact factor: 25.606

8.  Collagen deposition in HIV-1 infected lymphatic tissues and T cell homeostasis.

Authors:  Timothy W Schacker; Phuong L Nguyen; Gregory J Beilman; Steven Wolinsky; Matthew Larson; Cavan Reilly; Ashley T Haase
Journal:  J Clin Invest       Date:  2002-10       Impact factor: 14.808

9.  Suppression of leukemia inhibitor factor in lymphoid tissue in primary HIV infection: absence of HIV replication in gp130-positive cells.

Authors:  Annelie Tjernlund; Zareefa Fleener; Homira Behbahani; Elizabeth Connick; Anders Sönnerborg; Christina Broström; Li-Ean Goh; Anna-Lena Spetz; Bruce K Patterson; Jan Andersson
Journal:  AIDS       Date:  2003-06-13       Impact factor: 4.177

10.  HIV infection of naturally occurring and genetically reprogrammed human regulatory T-cells.

Authors:  Kyra Oswald-Richter; Stacy M Grill; Nikki Shariat; Mindy Leelawong; Mark S Sundrud; David W Haas; Derya Unutmaz
Journal:  PLoS Biol       Date:  2004-07-13       Impact factor: 8.029

View more
  2 in total

Review 1.  Chronic innate immune activation as a cause of HIV-1 immunopathogenesis.

Authors:  Adriano Boasso; Gene M Shearer
Journal:  Clin Immunol       Date:  2007-10-03       Impact factor: 3.969

2.  HIV-induced type I interferon and tryptophan catabolism drive T cell dysfunction despite phenotypic activation.

Authors:  Adriano Boasso; Andrew W Hardy; Stephanie A Anderson; Matthew J Dolan; Gene M Shearer
Journal:  PLoS One       Date:  2008-08-13       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.